Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

David Planchard(Institut Gustave Roussy), Sanjay Popat(Royal Marsden Hospital), Keith M. Kerr(Aberdeen Royal Infirmary), Silvia Novello(University of Turin), Egbert F. Smit(The Netherlands Cancer Institute), Corinne Faivre‐Finn(University of Manchester), Tony Mok(Chinese University of Hong Kong), Martin Reck(German Center for Lung Research), Paul E. Van Schil(Antwerp University Hospital), Matthew D. Hellmann(Cornell University), Solange Peters(University Hospital of Lausanne)
Annals of Oncology
July 26, 2018
10.1093/annonc/mdy275
Cited by 2,289Open Access
Full Text

Abstract

Related Papers

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
David M. Hyman, Igor Puzanov, Vivek Subbiah et al.|New England Journal of Medicine|2015|1.7k
WHO classification of tumours of the lung, pleura, thymus and heart
William D. Travis|International Agency for Research on Cancer eBooks|2015|1.7k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto, Norbert Kased, David Roberge et al.|Journal of Clinical Oncology|2011|1.4k
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
Frank V. Fossella, Russell F. DeVore, Ronald N. Kerr et al.|Journal of Clinical Oncology|2000|1.4k
Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion
Helen Davies, Eleanor Mishra, Brennan C Kahan et al.|JAMA|2012|638